Atıf Formatları
Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

İ. Beypınar Et Al. , "Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study," Breast Cancer Research and Treatment , vol.208, no.3, pp.597-604, 2024

Beypınar, İ. Et Al. 2024. Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study. Breast Cancer Research and Treatment , vol.208, no.3 , 597-604.

Beypınar, İ., Demir, H., YASLIKAYA, Ş., KÖŞECİ, T., Demir, B., Çolak, G., ... AĞAOĞLU, A. B.(2024). Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study. Breast Cancer Research and Treatment , vol.208, no.3, 597-604.

Beypınar, İsmail Et Al. "Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study," Breast Cancer Research and Treatment , vol.208, no.3, 597-604, 2024

Beypınar, İsmail Et Al. "Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study." Breast Cancer Research and Treatment , vol.208, no.3, pp.597-604, 2024

Beypınar, İ. Et Al. (2024) . "Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study." Breast Cancer Research and Treatment , vol.208, no.3, pp.597-604.

@article{article, author={İsmail Beypınar Et Al. }, title={Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study}, journal={Breast Cancer Research and Treatment}, year=2024, pages={597-604} }